Loading...
Loading...
In a report published Thursday, Deutsche Bank analyst Shawn Bevec initiated coverage on
Examworks GroupEXAM with a Buy rating and $38.00 price target.
In the report, Deutsche Bank noted, “EXAM is the clear market leader in the niche, highly fragmented ~$6 bln independent medical examination (IME) market. The company has built a long term competitive advantage in the IME market by acquiring 46 smaller operators to become the only player with a national footprint across three of its four geographies. Together with an unrivaled IT infrastructure to streamline the IME process and offer superior data security, EXAM is uniquely positioned to significantly grow its market share long term through accelerated organic revenue growth and future tuck-in acquisitions.”
Examworks Group closed on Wednesday at $28.71.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in